Preview Company (Stock code) Date/time Event Presenter
Tackling Australia's infrastructure challenges and funding our future
AUSTRALIAN BRITISH CHAMBER OF COMMERCE (5BCC) Wed, 16 Mar 2016 12:00 pm (UK time) Tackling Australia's infrastructure challenges and funding our future Antony Cahill - Group Executive Product & Markets, National Australia Bank
Uranium sale contracts underpin Lance Project
PENINSULA ENERGY LIMITED (PEN) Wed, 16 Mar 2016 12:00 pm (UK time) Uranium sale contracts underpin Lance Project John (Gus) Simpson, Managing Director & CEO - Managing Director & CEO
Strong Half-Year Production and Profit Results for Doray
DORAY MINERALS LIMITED (DRM) Tue, 15 Mar 2016 04:45 pm (UK time) Strong Half-Year Production and Profit Results for Doray Allan Kelly, Managing Director - Managing Director
amaysim: HY16 Results Investor Update
AMAYSIM AUSTRALIA LIMITED (AYS) Tue, 15 Mar 2016 02:30 pm (UK time) amaysim: HY16 Results Investor Update Julian Ogrin - CEO & Managing Director
Major technological advancement of its SNAP technology
BRAINCHIP HOLDINGS LTD (BRN) Tue, 15 Mar 2016 01:00 pm (UK time) Major technological advancement of its SNAP technology Peter van der Made - CTO
Ahalife Company Update
AHAlife (AHL) Tue, 15 Mar 2016 11:30 am (UK time) Ahalife Company Update Shauna Mei - CEO & Founder
eServGlobal - HomeSend progress update
ESERVGLOBAL LIMITED (ESG) Mon, 14 Mar 2016 08:00 am (UK time) eServGlobal - HomeSend progress update John Conoley - Executive Chairman, eServGlobal
Forbidden Technologies - First South African public sector sale
FORBIDDEN TECHNOLOGIES (FBT) Fri, 11 Mar 2016 08:55 pm (UK time) Forbidden Technologies - First South African public sector sale Aziz Musa - CEO
PPHE Hotel Group Limited - Results for the year to 31 December 2015
PPHE HOTEL GROUP (PPH) Fri, 11 Mar 2016 12:40 am (UK time) PPHE Hotel Group Limited - Results for the year to 31 December 2015 Chen Moravsky - Deputy Chief Executive Officer and Chief Financial Officer
Summit Therapeutics - Initial trials of ridinilazole
SUMMIT THERAPEUTICS (SUMM) Thu, 10 Mar 2016 11:05 pm (UK time) Summit Therapeutics - Initial trials of ridinilazole Mark Wilcox - Professor